[1]
D. S. Kahraman, “Prognostic impact of BCL2, BCL6 and MYC status in de novo diffuse large B-cell lymphoma: a regional study of 43 patients”, Int J Res Med Sci, vol. 7, no. 5, pp. 1720–1726, Apr. 2019.